Breastfeeding Advices on OTC Medicines With the Internet: What is the Best Medium

NCT06863597 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2025-03-11

No results posted yet for this study

Summary

Pharmacotherapy for lactating women in Hungary presents a unique challenge. While certain medications may pose risks to the infant or reduce breast milk production, the unnecessary avoidance of treatment can also be harmful. Despite this, no dedicated Hungarian website currently provides guidance on the safe use of over-the-counter (OTC) medications for breastfeeding mothers.

To address this gap, the aim is to develop a website that not only meets clinical standards but also presents essential information in a clear, accessible format that helps mothers understand and retain key details by choosing the best medium.

Our main question is: What is the most effective way to educate lactating women about OTC medication use through an online platform?

Conditions

  • Breastfeeding Education
  • Lactating Mother
  • Breastfeeding Mothers
  • Lactation
  • Breastfeeding

Interventions

OTHER

Video content

Video content produced by media professionals using expert opinions.

OTHER

Written content

Written content produced by healthcare professionals with experience in health education.

OTHER

Podcast content

Podcast content created by media experts based on expert opinions.

OTHER

Illustration (information leaflet) content

Illustration-based content created by media experts using expert opinions.

Sponsors & Collaborators

  • Semmelweis University

    lead OTHER

Principal Investigators

  • Dénes Kleiner, PhD · Semmelweis University, University Pharmacy Department of Pharmacy Administration

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2027-04-30
Completion
2027-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06863597 on ClinicalTrials.gov